Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · IEX Real-Time Price · USD
39.61
-0.14 (-0.35%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Amphastar Pharmaceuticals Market Cap
Amphastar Pharmaceuticals has a market cap or net worth of $1.94 billion as of July 22, 2024. Its market cap has decreased by -29.83% in one year.
Market Cap
1.94B
Enterprise Value
2.27B
1-Year Change
-29.83%
Ranking
Category
Stock Price
$39.61
Market Cap Chart
Since June 25, 2014, Amphastar Pharmaceuticals's market cap has increased from $374.20M to $1.94B, an increase of 417.64%. That is a compound annual growth rate of 17.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 1.94B | -34.63% |
| Dec 29, 2023 | 2.96B | 118.81% |
| Dec 30, 2022 | 1.35B | 21.52% |
| Dec 31, 2021 | 1.11B | 16.65% |
| Dec 31, 2020 | 955.30M | 5.51% |
| Dec 31, 2019 | 905.40M | -1.31% |
| Dec 31, 2018 | 917.40M | 3.71% |
| Dec 29, 2017 | 884.60M | 4.34% |
| Dec 30, 2016 | 847.80M | 32.34% |
| Dec 31, 2015 | 640.60M | 23.57% |
| Dec 31, 2014 | 518.40M | 38.54% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recursion Pharmaceuticals | 1.99B |
| NovoCure | 1.98B |
| Syndax Pharmaceuticals | 1.96B |
| Arvinas | 1.95B |
| Novavax | 1.94B |
| LeMaitre Vascular | 1.93B |
| Alignment Healthcare | 1.93B |
| National HealthCare | 1.92B |